Brief report · 29 Dec 2025
Case reportPublished 2019
Plasmablastic Lymphomas of the Oral Cavity: About a Case
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Plasmablastic lymphoma is a variant of diffuse large B-cell lymphoma, observed mainly in the oral cavity in the immune compromised. Pathologists poorly recognize plasmoblastic lymphoma, in part because of its relatively rare appearance and unusual immunophenotype. We admitted a 63-year-old patient with a history of ischemic stroke 6 years ago to supplement the management of recurrent non-Hodgkin’s lymphoma a (NHL). A biopsy for pathological confirmation is requested and results as follows: Immunohistochemical profile in favor of plasmoblastic lymphoma (Tumor cells are of a lymphoid nature weakly expressing the leukocyte common antigen LAC-B117PD7/26-DAKO, antibodies anti-CD138 expressed diffuse, anti-CD20, CD3, CD5, CD10, CD30 negative, anti-cytokeratin antibodies AE1 negative, anti-HMB45 negative The proliferation index Ki67: 60%. Magnetic resonance imaging found: a residual polyolobed tumoral mass of 41 × 17 mm attached to the level of the tongue’s brake, then infiltrating the floor to the level of digastric muscles pouring right after administration of contrast medium. He has benefited from 6 cures of chemotherapy with the DAEPOCH protocol, first cure on 13/09/2017 and sixth on 27/12/2017. The reassessment report showed a good clinical response on the end-of-treatment CT scan on 15/01/2018. The patient presents himself 6 months later with another local recurrence. It benefits from radiotherapy on the oral floor at the dose of 40 gray. The plasmoblastic lymphomas represent a distinct new subtype among diffuse large B cell lymphomas. The individualization of this new class of lymphoma provides a solid foundation for other molecular analyzes to define its pathogen.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Oncology Medicine & Practice.
Brief report · 29 Dec 2025
Radiotherapy's Immune Microenvironment Shift Enhances Immunotherapy
Commentary · 29 Dec 2025
Novel Biomarker Panels for Early HCC Detection
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Oncology Medicine & Practice
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Wilfried MBA”
- BylineArticles whose byline prints “Bertr”
- BylineArticles whose byline prints “Evrard S”
- BylineArticles whose byline prints “El-Majjaoui S”
- BylineArticles whose byline prints “El-Kacemi H”
- BylineArticles whose byline prints “Kebdani T”
- BylineArticles whose byline prints “Benjaafar N”
